{"result": "(\"entity\"<|>EHCA<|>EVENT<|>EHCA refers to the advanced stages of liver disease, characterized by metabolic alterations and nutritional challenges faced by patients.)\n##\n(\"entity\"<|>CIRROSIS<|>EVENT<|>Cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism.)\n##\n(\"entity\"<|>SARCOPENIA<|>EVENT<|>Sarcopenia is the loss of muscle mass and strength that occurs in patients with liver disease, particularly in advanced stages.)\n##\n(\"entity\"<|>NUTRITIONAL INTERVENTION<|>EVENT<|>Nutritional intervention is the process of providing dietary support to patients with liver disease to improve their nutritional status and overall health.)\n##\n(\"entity\"<|>AMMONIA<|>EVENT<|>Ammonia is a compound that can accumulate in the body and is associated with metabolic disturbances in patients with liver disease.)\n##\n(\"entity\"<|>LEUCINE<|>EVENT<|>Leucine is an essential amino acid that plays a critical role in protein synthesis and muscle metabolism, particularly in patients with liver disease.)\n##\n(\"entity\"<|>GLUCOSA<|>EVENT<|>Glucose is a simple sugar that is an important energy source in living organisms, and its availability is crucial for metabolic processes.)\n##\n(\"entity\"<|>INSULINA<|>EVENT<|>Insulin is a hormone that regulates glucose levels in the blood and plays a significant role in metabolism, particularly in patients with liver disease.)\n##\n(\"relationship\"<|>EHCA<|>CIRROSIS<|>EHCA is a condition that often results from the progression of cirrhosis in patients with liver disease<|>8)\n##\n(\"relationship\"<|>CIRROSIS<|>SARCOPENIA<|>Cirrhosis can lead to sarcopenia due to metabolic alterations and nutritional deficiencies<|>7)\n##\n(\"relationship\"<|>SARCOPENIA<|>NUTRITIONAL INTERVENTION<|>Nutritional intervention is often necessary to address sarcopenia in patients with liver disease<|>6)\n##\n(\"relationship\"<|>EHCA<|>AMMONIA<|>Increased ammonia levels are associated with metabolic disturbances in patients with EHCA<|>5)\n##\n(\"relationship\"<|>LEUCINE<|>SARCOPENIA<|>Leucine is essential for muscle protein synthesis, which is critical in preventing sarcopenia<|>6)\n##\n(\"relationship\"<|>GLUCOSA<|>INSULINA<|>Insulin regulates glucose levels, which is vital for metabolic processes in patients with liver disease<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: a la hora de acostarse, se puede disminuir este catabolismo acelerado47.\n\n### 7.3.2. Metabolismo lipídico\n\nEstá aumentada la lipólisis y la oxidación de lípidos48, que son utilizados como fuente de energía ante la disminución de disponibilidad de la glucosa, con el resultado de pérdida de masa grasa corporal. Esta movilización de lípidos ocurre a pesar de los altos niveles de insulina. Incluso en situación postprandial la oxidación de lípidos sigue aumentada49. Este fenómeno es más notable durante el ayuno, cuando los lípidos aportan el 75% de la energía requerida, el doble que en sujetos sanos en las mismas condiciones.\n\nSe ha descrito un descenso de ácidos grasos esenciales y otros poliinsaturados, en correlación con el grado de malnutrición y la severidad de la insuficiencia de la función hepática50, 51.\n\n### 7.3.3. Metabolismo proteico\n\nEstá profundamente alterado en la EHCA. El catabolismo proteico está ya acelerado desde los estadios iniciales de la enfermedad, y empeora a medida que esta progresa52. Las proteínas son utilizadas para neoglucogénesis. Pueden existir alteraciones en el metabolismo de los aminoácidos. La tirosina y la cisteína pueden hacerse esenciales en la EHC. Como consecuencia de este catabolismo proteico ocurre una depleción de masa muscular, la sarcopenia.\n\nA la pérdida de proteínas contribuyen, entre otros factores, las parecentesis evacuadoras, pérdidas hemá-\n\nticas por varices esofágicas o gástricas, ulceraciones intestinales o enteropatía12. No obstante, los pacientes cirróticos estables pueden retener nitrógeno y sintetizar masa magra con una nutrición adecuada53.\n\nLa hiperamoniemia está ganando atención como posible mediador del eje hígado-músculo. El aumento de amonio muscular activa un programa de alteraciones moleculares y metabólicas en el músculo, con alteración del intercambio de leucina por glutamina, daño en la señal por leucina, aumento de expresión de miostatina, disfunción mitocondrial, aumento de las especies reactivas de oxígeno, disminución de la síntesis proteica y aumento de proteólisis mediada por autofagia54. Todo ello contribuye a la sarcopenia, a la resistencia anabólica y la inadecuada respuesta a la suplementación nutricional en pacientes cirróticos. Otros mediadores propuestos en el eje hígado-músculo son la endotoxemia, y la disminución de testosterona y hormona de crecimiento.\n\n### 7.4. Alteraciones del gasto energético\n\nLa mayor parte de los pacientes con EHCA tienen un gasto metabólico normal. Sin embargo, se ha documentado la elevación del mismo hasta en un 33% de los pacientes55, 56. Este hipermetabolismo se asocia con pérdida de masa muscular, masa celular corporal y masa extracelular y con una menor supervivencia tras trasplante hepático57. Puede persistir más de un año después del trasplante58. Puesto que la presencia de hipermetabolismo no es predecible en base a factores clínicos, severidad o características de la enfermedad hepática, es recomendable realizar calorimetría indirecta para conocer el gasto metabólico59. Se ha descrito también hipermetabolismo durante las complicaciones de la cirrosis, tales como ascitis o hepatocarcinoma60, 61.\n\nLa termogénesis inducida por los alimentos y el gasto energético asociado a actividad física permanecen dentro de la normalidad en pacientes cirróticos62.\n\n## 8. Valoración del estado nutricional\n\nA pesar del cuerpo de conocimiento generado por la investigación en metabolismo y nutrición clínica, no hay acuerdo ni estandarización para el diagnóstico y la clasificación de la malnutrición en pacientes con EHC.\n\nLa valoración nutricional del paciente con enfermedad hepática puede ser difícil, y muchos de los parámetros de valoración nutricional, útiles en otras situaciones, pueden resultar poco fiables debido a alteraciones de la homeostasis de fluidos y del metabolismo proteico. La utilización de varios de ellos conjuntamente aumenta la fiabilidad de la valoración nutricional. En algunos pacientes en estadios avanzados de la EHC el diagnóstico de malnutrición puede ser obvio; en otras situaciones, decidir si un paciente está o no malnutrido y en qué grado, puede resultar complicado. En cualquier caso, la\n---\n## BLOQUE: PROTEÍNAS Y AMINOÁCIDOS\n\nLa valoración nutricional es crucial en la evaluación completa del paciente cirrótico, así como reconocer la posible necesidad de intervención nutricional.\n\nEl\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}